A partial form of inherited human USP18 deficiency underlies infection and inflammation - Institut Pasteur Access content directly
Journal Articles Journal of Experimental Medicine Year : 2022

A partial form of inherited human USP18 deficiency underlies infection and inflammation

Zhi Li
Alan Sher

Abstract

Human USP18 is an interferon (IFN)-stimulated gene product and a negative regulator of type I IFN (IFN-I) signaling. It also removes covalently linked ISG15 from proteins, in a process called deISGylation. In turn, ISG15 prevents USP18 from being degraded by the proteasome. Autosomal recessive complete USP18 deficiency is life-threatening in infancy owing to uncontrolled IFN-I–mediated autoinflammation. We report three Moroccan siblings with autoinflammation and mycobacterial disease who are homozygous for a new USP18 variant. We demonstrate that the mutant USP18 (p.I60N) is normally stabilized by ISG15 and efficient for deISGylation but interacts poorly with the receptor-anchoring STAT2 and is impaired in negative regulation of IFN-I signaling. We also show that IFN-γ–dependent induction of IL-12 and IL-23 is reduced owing to IFN-I–mediated impairment of myeloid cells to produce both cytokines. Thus, insufficient negative regulation of IFN-I signaling by USP18-I60N underlies a specific type I interferonopathy, which impairs IL-12 and IL-23 production by myeloid cells, thereby explaining predisposition to mycobacterial disease.
Fichier principal
Vignette du fichier
jem_20211273.pdf (6.2 Mo) Télécharger le fichier
Origin : Publication funded by an institution

Dates and versions

pasteur-03684590 , version 1 (01-06-2022)

Licence

Attribution - NonCommercial - ShareAlike

Identifiers

Cite

Marta Martin-Fernandez, Sofija Buta, Tom Le Voyer, Zhi Li, Lasse Toftdal Dynesen, et al.. A partial form of inherited human USP18 deficiency underlies infection and inflammation. Journal of Experimental Medicine, 2022, 219 (4), ⟨10.1084/jem.20211273⟩. ⟨pasteur-03684590⟩
20 View
123 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More